↓ Skip to main content

XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)

Overview of attention for article published in Journal of Hematology & Oncology, October 2014
Altmetric Badge

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
Published in
Journal of Hematology & Oncology, October 2014
DOI 10.1186/1756-8722-7-46
Pubmed ID
Authors

Giovanni Luca Gravina, Monica Tortoreto, Andrea Mancini, Alessandro Addis, Ernesto Di Cesare, Andrea Lenzi, Yosef Landesman, Dilara McCauley, Michael Kauffman, Sharon Shacham, Nadia Zaffaroni, Claudio Festuccia

Abstract

Exportin 1 (XPO1), also called chromosome region maintenance 1 (CRM1), is the sole exportin mediating transport of many multiple tumor suppressor proteins out of the nucleus.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Denmark 1 2%
Unknown 41 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 16%
Student > Bachelor 7 16%
Student > Ph. D. Student 6 14%
Professor > Associate Professor 3 7%
Student > Master 3 7%
Other 8 19%
Unknown 9 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 16%
Medicine and Dentistry 6 14%
Engineering 4 9%
Agricultural and Biological Sciences 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Other 8 19%
Unknown 12 28%